Clinical Success Rates and What is Driving Them

9:00 AM - 9:45 AM (EST), Wednesday, February 17, 2021

A new report on industry clinical success rates will be released at BIO CEO 2021. Join the authors from Informa, QLS, and BIO for a discussion on the key findings from the report, including comparisons of success rates across indications and modalities, regulatory factors, timing of clinical phase transitions, and predictive factors driving successes and failures in drug development. This new data will help shape risk profiles and valuation metrics across investment and pharma R&D portfolios.  Read the report here.

Moderators
photo
General Manager - Americas
Informa
photo
Vice President, Industry Research
Biotechnology Innovation Organization
Speakers
photo
Managing Director
Blackstone Life Sciences
photo
Thought Leadership Director
Informa
photo
CTO
QLS Advisors
photo
General Manager - Americas
Informa
photo
Director of Content, Biomedtracker
Informa
photo
Co-Founder
QLS Advisors
photo
Vice President, Industry Research
Biotechnology Innovation Organization